Research into dry eye disease (keratoconjunctivitis sicca) identifies chronic inflammation and oxidative stress in eye tissue as common features stemming from various causes such as aging, contact lens use, and decreased tear production. The study explores potential treatments inspired by plant biology to address these conditions.

Semaglutide is associated with a 26% reduction in the predicted risk of developing dementia over five years. This finding suggests potential cognitive benefits of the drug beyond its use for weight management and diabetes.